Relay Therapeutics (NASDAQ: RLAY) officer eyes another stock sale after June trade

Rhea-AI Filing Summary

Relay Therapeutics, Inc. (RLAY) reports that officer Peter Rahmer has filed a Rule 144 notice to sell up to 50,000 shares of common stock through Morgan Stanley Smith Barney LLC. The planned sale has an aggregate market value of $1,028,500, with an approximate sale date of 08/26/2026 on NASDAQ. The shares relate to Restricted Stock Units granted on 01/28/2025 by the issuer. Relay Therapeutics states that 219,141,631 shares of common stock are outstanding. The filing also notes prior 10b5-1 plan sales of 50,000 shares for $954,560 on 06/30/2026.

Key Figures

Shares to be sold: 50,000 shares of common stock Aggregate market value of planned sale: $1,028,500.00 Shares outstanding: 219,141,631 shares +4 more

7 metrics

Shares to be sold 50,000 shares of common stock Planned sale by officer Peter Rahmer under Rule 144

Aggregate market value of planned sale $1,028,500.00 Estimated value of 50,000 shares to be sold

Shares outstanding 219,141,631 shares Common stock outstanding for Relay Therapeutics, Inc.

Approximate sale date 08/26/2026 Planned date for Rule 144 sale on NASDAQ

Recent 10b5-1 sale shares 50,000 shares Shares sold on 06/30/2026 under a 10b5-1 plan

Recent 10b5-1 sale proceeds $954,560.00 Aggregate sale price for 50,000 shares on 06/30/2026

RSU grant date 01/28/2025 Restricted Stock Units from which the 50,000 shares arise

Key Terms

Rule 144, Restricted Stock Units, 10b5-1, aggregate market value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 01/28/2025 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 regulatory

"10b5-1 Sales for PETER RAHMER 60 Hampshire Street"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

aggregate market value financial

"50000 | 1028500.00 | 219141631 | 08/26/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does the Form 144 filing for RLAY disclose about planned insider sales?

The notice states that officer Peter Rahmer plans to sell up to 50,000 shares of Relay Therapeutics common stock under Rule 144, with an aggregate market value of $1,028,500, through Morgan Stanley Smith Barney LLC, with an approximate sale date of 08/26/2026 on NASDAQ.

How many RLAY shares are outstanding according to this Form 144?

Relay Therapeutics reports that there are 219,141,631 shares of common stock outstanding in connection with this Rule 144 notice. This figure provides context for the 50,000 shares that may be sold by officer Peter Rahmer.

What is the origin of the RLAY shares Peter Rahmer plans to sell?

The 50,000 shares covered by the Form 144 relate to Restricted Stock Units granted on 01/28/2025 by Relay Therapeutics. The filing identifies the issuer as the source of these securities.

Were there recent 10b5-1 plan sales disclosed for RLAY?

Yes. The filing notes 10b5-1 sales for Peter Rahmer of 50,000 shares of Relay Therapeutics common stock on 06/30/2026, with an aggregate sale price of $954,560. These occurred within the three months preceding the new planned sale.

Which broker is handling the planned RLAY share sale under Rule 144?

The planned sale of 50,000 shares of Relay Therapeutics common stock is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York, as disclosed in the Form 144 filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/26/2026 - 04:16 PM Accepted by SEC EDGAR 08/26/2026 - 04:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001959229
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	RELAY THERAPEUTICS INC
SEC File Number	001-39385
Address of Issuer	60 Hampshire Street Cambridge MASSACHUSETTS 02139
Phone	617-370-8837
Name of Person for Whose Account the Securities are To Be Sold	PETER RAHMER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	1028500.00	219141631	08/26/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/28/2025	Restricted Stock Units	Issuer			50000	01/28/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PETER RAHMER 60 Hampshire Street Cambridge MA 02139	Common	06/30/2026	50000	954560.00

144: Remarks and Signature

Remarks
Date of Notice	08/26/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/31/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Peter Rahmer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)